GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $701,000 | +223.0% | 10,300 | +51.2% | 0.05% | +165.0% |
| Q2 2022 | $217,000 | +261.7% | 6,810 | +290.0% | 0.02% | +300.0% |
| Q1 2022 | $60,000 | -6.2% | 1,746 | -20.6% | 0.01% | 0.0% |
| Q4 2021 | $64,000 | +255.6% | 2,200 | +514.5% | 0.01% | -58.3% |
| Q1 2020 | $18,000 | -61.7% | 358 | -60.2% | 0.01% | +140.0% |
| Q2 2019 | $47,000 | -33.8% | 900 | -52.4% | 0.01% | 0.0% |
| Q3 2018 | $71,000 | -15.5% | 1,890 | +1.1% | 0.01% | -16.7% |
| Q2 2018 | $84,000 | +236.0% | 1,869 | +251.3% | 0.01% | +200.0% |
| Q1 2018 | $25,000 | -73.4% | 532 | -77.8% | 0.00% | -77.8% |
| Q4 2017 | $94,000 | +422.2% | 2,394 | +295.0% | 0.01% | +350.0% |
| Q3 2017 | $18,000 | -48.6% | 606 | -53.3% | 0.00% | -33.3% |
| Q2 2017 | $35,000 | -74.1% | 1,298 | -64.6% | 0.00% | -78.6% |
| Q1 2017 | $135,000 | +145.5% | 3,664 | -5.3% | 0.01% | +133.3% |
| Q4 2016 | $55,000 | +71.9% | 3,870 | +173.7% | 0.01% | +50.0% |
| Q3 2016 | $32,000 | – | 1,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |